Coegin Pharma Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
3
- Stock Symbol
-
7Z6
- Investments
-
1
- Share Price
-
$0.19
- (As of Friday Closing)
Coegin Pharma General Information
Description
Coegin Pharma AB is a Swedish biotechnology company with projects in hair growth, skin pigmentation, heart attacks, and leukemia. Its project portfolio builds on three distinct, patented technology platforms: the FOL peptide technology, the pigmentation peptide technology, and the cPLA2 alpha technology. The company's project portfolio consists of both cosmetic dermatology and drug development projects. Currently, it is focused on the cosmetic dermatology projects, which include the NPP-4 project for skin pigmentation and the Follicopeptide project for hair growth. In addition, the company's project portfolio also includes three drug development projects: FOL026, for the treatment of myocardial infarction (heart attack); AVX420 for the treatment of leukemia; and AVX001.
Contact Information
Website
www.coeginpharma.comCorporate Office
- Medicon Village
- 223 81 Lund
- Sweden
Corporate Office
- Medicon Village
- 223 81 Lund
- Sweden
Coegin Pharma Stock Performance
As of 13-Nov-2026, Coegin Pharma’s stock price is $0.19. Its current market cap is $5.76M with 30.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.19 | $0.18 | $0.16 - $0.63 | $5.76M | 30.7M | 312.16 | -$0.09 |
Coegin Pharma Financials Summary
As of 30-Jun-2026, Coegin Pharma has a trailing 12-month revenue of $46.2K.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 8,699 | 9,026 | ||
| Revenue | 46 | 8 | 0 | 0 |
| EBITDA | (1,988) | (1,775) | (1,920) | (2,345) |
| Net Income | (2,318) | (2,086) | (2,249) | (2,632) |
| Total Assets | 833 | 1,450 | 2,451 | 1,544 |
| Total Debt | 0 | 0 | 0 | 0 |
Coegin Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Coegin Pharma Patents
Coegin Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4823538-A1 | Pharmaceutical composition | Pending | 15-Dec-2023 | ||
| WO-2025125241-A1 | Pharmaceutical composition | Inactive | 15-Dec-2023 | ||
| WO-2023218095-A1 | Agents for stimulating tissue regeneration | Inactive | 13-May-2022 | ||
| EP-4522191-A1 | Agents inducing vascularisation | Pending | 13-May-2022 | ||
| US-20250326799-A1 | Agents inducing vascularisation | Inactive | 13-May-2022 | C07K7/64 |
Coegin Pharma Signals
Coegin Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Coegin Pharma Acquisitions (1)
Coegin Pharma’s most recent deal was a Merger/Acquisition with Follicum. The deal was made on 07-Feb-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Follicum | 07-Feb-2022 | Merger/Acquisition | Drug Discovery |
Coegin Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Coegin Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Reccura Therapeutics | Trondheim, Norway | 2005 |
Coegin Pharma FAQs
-
When was Coegin Pharma founded?
Coegin Pharma was founded in 2005.
-
Where is Coegin Pharma headquartered?
Coegin Pharma is headquartered in Lund, Sweden.
-
What is the size of Coegin Pharma?
Coegin Pharma has 3 total employees.
-
What industry is Coegin Pharma in?
Coegin Pharma’s primary industry is Biotechnology.
-
Is Coegin Pharma a private or public company?
Coegin Pharma is a Public company.
-
What is Coegin Pharma’s stock symbol?
The ticker symbol for Coegin Pharma is 7Z6.
-
What is the current stock price of Coegin Pharma?
As of 13-Nov-2026 the stock price of Coegin Pharma is $0.19.
-
What is the current market cap of Coegin Pharma?
The current market capitalization of Coegin Pharma is $5.76M.
-
What is Coegin Pharma’s current revenue?
The trailing twelve month revenue for Coegin Pharma is $46.2K.
-
What is Coegin Pharma’s annual earnings per share (EPS)?
Coegin Pharma’s EPS for 12 months was -$0.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process